Incidence and relative risk of hepatic toxicity in patients treated with anti‐angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio… - British journal of …, 2014 - Wiley Online Library
Aim The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients
receiving tyrosine kinase inhibitors (TKIs) through a large up‐to‐date meta‐analysis of …
receiving tyrosine kinase inhibitors (TKIs) through a large up‐to‐date meta‐analysis of …
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy.
R Iacovelli, A Palazzo, G Procopio… - British Journal of …, 2014 - search.ebscohost.com
Aim The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
[引用][C] Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio, M Santoni… - British Journal of …, 2014 - cir.nii.ac.jp
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine
kinase inhibitors for malignancy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
kinase inhibitors for malignancy | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio… - British journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Aim The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy.
R Iacovelli, A Palazzo, G Procopio… - British Journal of …, 2014 - europepmc.org
Aim The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio… - BRITISH JOURNAL …, 2013 - iris.uniroma1.it
AIM: The aim of this study is to investigate the incidence and risk of hepatic toxicity in
patients receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis …
patients receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis …
Incidence and relative risk of hepatic toxicity in patients treated with anti‐angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio, M Santoni… - British Journal of Clinical …, 2014 - infona.pl
Aim The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients
receiving tyrosine kinase inhibitors (TKIs) through a large up‐to‐date meta‐analysis of …
receiving tyrosine kinase inhibitors (TKIs) through a large up‐to‐date meta‐analysis of …
[HTML][HTML] Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio… - British Journal of …, 2014 - ncbi.nlm.nih.gov
Aim The aim of this study is to investigate the incidence and risk of hepatic toxicity in patients
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis of …
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
R Iacovelli, A Palazzo, G Procopio… - BRITISH JOURNAL …, 2013 - iris.uniroma1.it
AIM: The aim of this study is to investigate the incidence and risk of hepatic toxicity in
patients receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis …
patients receiving tyrosine kinase inhibitors (TKIs) through a large up-to-date meta-analysis …